201 related articles for article (PubMed ID: 15643498)
1. Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma.
Lee SK; Moon J; Park SW; Song SY; Chung JB; Kang JK
Oncol Rep; 2005 Feb; 13(2):193-9. PubMed ID: 15643498
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin expression as a differentiation marker in gastric cancer.
Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Karatzas G
Hepatogastroenterology; 1998; 45(24):2437-42. PubMed ID: 9951940
[TBL] [Abstract][Full Text] [Related]
3. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation.
Resnick MB; Gavilanez M; Newton E; Konkin T; Bhattacharya B; Britt DE; Sabo E; Moss SF
Hum Pathol; 2005 Aug; 36(8):886-92. PubMed ID: 16112005
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype.
Sanada Y; Oue N; Mitani Y; Yoshida K; Nakayama H; Yasui W
J Pathol; 2006 Apr; 208(5):633-42. PubMed ID: 16435283
[TBL] [Abstract][Full Text] [Related]
5. Up-regulated claudin 7 expression in intestinal-type gastric carcinoma.
Park JY; Park KH; Oh TY; Hong SP; Jeon TJ; Kim CH; Park SW; Chung JB; Song SY; Bang S
Oncol Rep; 2007 Aug; 18(2):377-82. PubMed ID: 17611659
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical study of E-cadherin expression with correlations to clinicopathological features in gastric cancer.
Shun CT; Wu MS; Lin JT; Wang HP; Houng RL; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1998; 45(22):944-9. PubMed ID: 9755986
[TBL] [Abstract][Full Text] [Related]
7. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
Ascaño JJ; Frierson H; Moskaluk CA; Harper JC; Roviello F; Jackson CE; El-Rifai W; Vindigni C; Tosi P; Powell SM
Mod Pathol; 2001 Oct; 14(10):942-9. PubMed ID: 11598162
[TBL] [Abstract][Full Text] [Related]
9. Localization of ZO-1 and E-cadherin in the nasal polyp epithelium.
Jang YJ; Kim HG; Koo TW; Chung PS
Eur Arch Otorhinolaryngol; 2002 Oct; 259(9):465-9. PubMed ID: 12386748
[TBL] [Abstract][Full Text] [Related]
10. Aberrant retinal tight junction and adherens junction protein expression in an animal model of autosomal dominant Retinitis pigmentosa: the Rho(-/-) mouse.
Campbell M; Humphries M; Kennan A; Kenna P; Humphries P; Brankin B
Exp Eye Res; 2006 Sep; 83(3):484-92. PubMed ID: 16643895
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of claudin-4 between intestinal and diffuse-type gastric cancer.
Kuo WL; Lee LY; Wu CM; Wang CC; Yu JS; Liang Y; Lo CH; Huang KH; Hwang TL
Oncol Rep; 2006 Oct; 16(4):729-34. PubMed ID: 16969486
[TBL] [Abstract][Full Text] [Related]
12. Li-cadherin is inversely correlated with galectin-3 expression in gastric cancer.
Dong WG; Yu QF; Xu Y; Fan LF
Dig Dis Sci; 2008 Jul; 53(7):1811-7. PubMed ID: 17999183
[TBL] [Abstract][Full Text] [Related]
13. Reduction of syndecan-1 expression in differentiated type early gastric cancer and background mucosa with gastric cellular phenotype.
Watari J; Saitoh Y; Fujiya M; Shibata N; Tanabe H; Inaba Y; Okamoto K; Maemoto A; Ohta T; Yasuda A; Ayabe T; Ashida T; Yokota K; Obara T; Kohgo Y
J Gastroenterol; 2004; 39(2):104-12. PubMed ID: 15069616
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin expression correlates with tumor differentiation in colorectal cancer.
Karatzas G; Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Riza F; Papanikolaou D
Hepatogastroenterology; 1999; 46(25):232-5. PubMed ID: 10228798
[TBL] [Abstract][Full Text] [Related]
15. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.
Zhong XY; Zhang LH; Jia SQ; Shi T; Niu ZJ; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Ji JF
Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357
[TBL] [Abstract][Full Text] [Related]
16. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration.
Mayer B; Johnson JP; Leitl F; Jauch KW; Heiss MM; Schildberg FW; Birchmeier W; Funke I
Cancer Res; 1993 Apr; 53(7):1690-5. PubMed ID: 8453643
[TBL] [Abstract][Full Text] [Related]
18. Tight junction formation in epithelial ovarian adenocarcinoma.
Zhu Y; Sundfeldt K
Acta Obstet Gynecol Scand; 2007; 86(8):1011-9. PubMed ID: 17653889
[TBL] [Abstract][Full Text] [Related]
19. Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer.
Kinugasa T; Huo Q; Higashi D; Shibaguchi H; Kuroki M; Tanaka T; Futami K; Yamashita Y; Hachimine K; Maekawa S; Nabeshima K; Iwasaki H; Kuroki M
Anticancer Res; 2007; 27(6A):3729-34. PubMed ID: 17970035
[TBL] [Abstract][Full Text] [Related]
20. Paranuaclear E-cadherin in gastric adenocarcinoma.
Carpenter PM; Al-Kuran RA; Theuer CP
Am J Clin Pathol; 2002 Dec; 118(6):887-94. PubMed ID: 12472282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
